XLB News Alert Materials Select Sector SPDR (XLB) 49.87 11/18/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Materials Select Sector SPDR (XLB) 49.87 $XLB

The Best Offense Is A Good Defense
Eric Parnell, CFA - Seeking Alpha - Sat Nov 08, 8:36AM CST
What a difference a few weeks make. Stocks are once again in rally mode and bullishness is back on the street. After bottoming back on October 15, stocks as measured by the S&P 500 Index have rallied an impressive +11.6% to advance to fresh new...
XLB: 49.87 (+0.59), BDX: 130.94 (+1.40), SPLV: 37.14 (+0.15), DAL: 44.79 (+1.36), XLY: 69.33 (+0.13), BBY: 34.90 (-0.39), XLU: 45.66 (+0.13), SO: 47.25 (+0.17), XLV: 68.67 (+1.09), YHOO: 51.75 (-0.62), XLP: 48.26 (+0.18), SPY: 205.55 (+1.18), SPHB: 34.46 (+0.36), XLK: 41.67 (+0.14), PG: 87.95 (+0.11), XLI: 56.65 (+0.42), XLE: 85.83 (+0.07)

A Valuation Snapshot By Sectors
Fred Piard - at Seeking Alpha - Wed Nov 05, 9:09AM CST

XLB: 49.87 (+0.59), XLP: 48.26 (+0.18), XLY: 69.33 (+0.13), XLK: 41.67 (+0.14), XLI: 56.65 (+0.42), XLU: 45.66 (+0.13), XLF: 24.14 (+0.08), XLV: 68.67 (+1.09), XLE: 85.83 (+0.07)

VIS And VAW Come Together
Scott Arterburn - at Seeking Alpha - Tue Nov 04, 1:56PM CST

XLB: 49.87 (+0.59), SPY: 205.55 (+1.18), XLI: 56.65 (+0.42), VIS: 107.94 (+0.84), VAW: 111.25 (+1.16)

When Will Emerging Market ETFs Join The 'Risk-On' Party?
Gary Gordon - Seeking Alpha - Mon Nov 03, 1:35PM CST
When monetary policy leaders spoke in October, investors listened. Federal Reserve Open Market Committee (FOMC) member James Bullard suggested that his colleagues consider extending the U.S. central bank’s policy of buying bonds. In a similar...
1 Comment
DXJ: 54.64 (+0.77), VTI: 105.78 (+0.62), XLB: 49.87 (+0.59), SPY: 205.55 (+1.18), QQQ: 103.68 (+0.77), FXY: 83.26 (-0.35), YCS: 85.55 (+0.71), VWO: 41.81 (+0.21), EUO: 20.19 (-0.28)

Materials Sector Leading the Pack in Q3 Earnings Season: 3 ETFs in Focus - ETF News And Commentary
Sweta Killa - ZACKS - Thu Oct 30, 2:00PM CDT
These ETFs could be worth a look given that materials sector is the largest contributor to Q3 earnings growth so far.
XLB: 49.87 (+0.59), IYM: 86.12 (+0.96), DD: 71.16 (+0.69), DOW: 52.07 (+0.95), VAW: 111.25 (+1.16)

Are XLB And Materials Overpriced?
Fred Piard - at Seeking Alpha - Thu Oct 30, 1:46PM CDT

XLB: 49.87 (+0.59), LYB: 89.04 (+1.34), MON: 119.33 (+0.95), DD: 71.16 (+0.69), PX: 127.83 (+1.57), PPG: 208.50 (+3.17), DOW: 52.07 (+0.95), APD: 138.90 (+3.09), ECL: 113.18 (+0.99)

Asset Class Performance Since The October 15th Short-Term Low
Bespoke Investment Group - Seeking Alpha - Thu Oct 23, 12:03AM CDT
Below is a look at how various asset classes (using tradeable ETFs) have performed since stocks put in a short-term bottom on October 15th. For each ETF, we also include its performance so far this month and year. As shown, US equities have surged...
INP: 74.38 (+0.48), XLB: 49.87 (+0.59), QQQ: 103.68 (+0.77), IJH: 143.59 (+0.85), RSX: 20.78 (+0.20), TLT: 119.52 (+0.33), XLV: 68.67 (+1.09), XLE: 85.83 (+0.07)

Industrial ETF: No. 8 Select Sector SPDR Over 2014's First 9 Months
J.J. McGrath - at Seeking Alpha - Fri Oct 17, 2:28PM CDT

XLB: 49.87 (+0.59), SPY: 205.55 (+1.18), XLK: 41.67 (+0.14), XLI: 56.65 (+0.42)

2 Promising ETFs and Stocks from Q3's Hot Sector - ETF News And Commentary
Sweta Killa - ZACKS - Tue Oct 14, 12:00PM CDT
Investor should consider these material ETFs and stocks to benefit from Q3 earnings season.
XLB: 49.87 (+0.59), MON: 119.33 (+0.95), IYM: 86.12 (+0.96), DD: 71.16 (+0.69), AKS: 6.39 (-0.05), DOW: 52.07 (+0.95), GG: 21.29 (+0.72)

Notable ETF Outflow Detected - XLB, DOW, MON, DD
ETFChannel.com - Tue Aug 26, 9:54AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Materials Select Sector SPDR Fund where we have detected an approximate $128.4 million dollar outflow -- that's a 2.3%...
XLB: 49.87 (+0.59)

DuPont and Dow Chemical Earnings Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - ZACKS - Fri Jul 25, 1:00PM CDT
The mixed results from the two chemical titans put materials ETFs in focus for the coming days.
XLB: 49.87 (+0.59), IYM: 86.12 (+0.96), DD: 71.16 (+0.69), DOW: 52.07 (+0.95), VAW: 111.25 (+1.16)

First Week of XLB March 2015 Options Trading
DividendChannel.com - Thu Jul 24, 9:48AM CDT
Investors in Materials Select Sector SPDR Fund saw new options begin trading this week, for the March 2015 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until...
XLB: 49.87 (+0.59)

Utilities, Energy, Health Care Are the ETFs to Beat This Year
at The Street - Thu Jul 03, 10:10AM CDT
I track 11 exchange-traded funds, and the best year-to-date performer is utilities, while health care set an all-time high on Wednesday.
XLB: 49.87 (+0.59), XLP: 48.26 (+0.18), XLY: 69.33 (+0.13), IYC: 131.10 (+0.52), XLK: 41.67 (+0.14), XLI: 56.65 (+0.42), XLU: 45.66 (+0.13), XLF: 24.14 (+0.08), IYT: 162.22 (+0.51), XLV: 68.67 (+1.09), XLE: 85.83 (+0.07)

Materials ETFs in Focus as DuPont Cuts Guidance - ETF News And Commentary
Sweta Killa - ZACKS - Mon Jun 30, 2:00PM CDT
Investors should closely watch the movement of these ETFs following disappointing outlook by DuPont.
XLB: 49.87 (+0.59), IYM: 86.12 (+0.96), DD: 71.16 (+0.69), VAW: 111.25 (+1.16)

Monsanto Stock Strength Is Great for These ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Jun 27, 9:00AM CDT
With the solid guidance and earnings beat from Monsanto (MON), these materials ETFs could benefit.
XLB: 49.87 (+0.59), MON: 119.33 (+0.95), MOO: 55.55 (+0.68), IYM: 86.12 (+0.96), VEGI: 27.43 (+0.35)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 135

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 177

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 14

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 12

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

What Your $1000 Investment in ASML Could Be Worth Now

Updated Category News Views 269

Exploring ASML Holding's Remarkable Growth ASML Holding (NASDAQ: ASML) has established itself as a leader in the semiconductor industry, offering substantial growth for investors. Over the past 15 years, the stock has consistently outperformed the market, delivering an impressive annualized return of 23.78%. This performance exceeds the overall market's growth by 11.35%,...

Continue Reading
Nvidia and Adobe Lead Stock Movement Trends This Week

Updated Category News Views 87

Significant Stock Movements in Today's Market Today's trading session has brought notable activity in the stock market, particularly among mega-cap and large-cap companies. With significant price fluctuations and market activity, investors are closely analyzing trends influenced by various factors, such as earnings reports and market sentiment. Mega-Cap Market Movers When...

Continue Reading
Charlotte's Web Unveils Innovative Quiet Sleep Mushroom Gummies

Updated Category News Views 184

Charlotte's Web Launches Quiet Sleep Mushroom Gummies A recent survey highlights that 43% of Americans struggle with sleep due to racing thoughts. To address this common issue, Charlotte's Web Holdings, Inc. introduces a natural remedy in the form of Quiet Sleep Mushroom Gummies. These gummies are melatonin-free and free from CBD, utilizing the calming properties of...

Continue Reading
Brown Brothers Harriman Expands Team with New Senior Wealth Planner

Updated Category News Views 258

Brown Brothers Harriman Enhances Wealth Planning Services Brown Brothers Harriman & Co. (BBH) has taken a significant step in strengthening its Chicago presence by welcoming Kristina White as a Senior Wealth Planner. With years of experience as a Managing Director and Partner at McDermott Will & Emery, Kristina brings a wealth of expertise in sophisticated wealth...

Continue Reading
Hospitality Sector Innovates to Overcome Market Challenges

Updated Category News Views 78

Hospitality Sector Innovates to Tackle Market Challenges In recent years, hospitality stocks have contended with major obstacles, including economic uncertainties and shifts in global markets. Despite these challenges, this industry has shown remarkable resilience, continually adapting and innovating to thrive amid adversity. As Wall Street watches for economic changes,...

Continue Reading